Quick Answer (for busy buyers)
Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.
- In the US, stretch mark products are regulated as cosmetics by the FDA, so allowed claims are cosmetic, such as ‘reduces the appearance of stretch marks’ or ‘enhances skin hydration.’ Avoid claims like ‘prevents stretch marks’ or ‘treats scars,’ which imply drug effects and require FDA approval, risking regulatory action.
- From our OEM/ODM workflow, typical MOQ starts at 3,000-5,000 units per SKU to optimize costs, with sampling taking 4-6 weeks for formulation stability and skin compatibility checks.
- We conduct testing like microbial analysis and patch tests, and ensure packaging meets US labeling laws, including INCI lists and child-safe caps if needed.
- Lead time from final approval to production is 8-12 weeks, depending on component sourcing.
- We assist with documentation such as safety reports and PIFs, but brand owners must verify claim compliance with legal experts.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.